Home/Filings/4/0001593968-19-000396
4//SEC Filing

Orlando Daniel 4

Accession 0001593968-19-000396

CIK 0000887359other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:07 PM ET

Size

9.8 KB

Accession

0001593968-19-000396

Insider Transaction Report

Form 4
Period: 2019-02-06
Orlando Daniel
Interim CEO
Transactions
  • Award

    Restricted Stock Unit

    2019-02-06+14,00014,000 total
    Common Stock (14,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-06+9,3039,303 total
    Exercise: $16.66From: 2019-05-06Exp: 2029-02-06Common Stock (9,303 underlying)
  • Award

    Stock Option (right to buy)

    2019-02-06+130,697130,697 total
    Exercise: $16.66From: 2019-05-06Exp: 2029-02-06Common Stock (130,697 underlying)
Footnotes (4)
  • [F1]These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
  • [F2]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
  • [F3]These RSUs vest in four annual installments with 3,500 RSUs vesting on February 6, 2020, February 6, 2021, February 6, 2022, and February 6, 2023, respectively.
  • [F4]No expiration date for this type of award.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001563759

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:07 PM ET
Size
9.8 KB